[ad_1] Enter Wall Street with StreetInsider Premium. Claim your free 2 week trial here. Johnson & Johnson (NYSE: JNJ) announced today its agreement with Ci: z Holdings Co., Ltd. (4924) (the "Company"), …
Read More »Single dose of J & J's Stelara shows treatment effect in late-stage advanced cancer study – Johnson & Johnson (NYSE: JNJ)
[ad_1] Results from a Phase 3 clinical trial, UNIFI, on Janssen Pharmaceuticals (NYSE: JNJ) STELARA (ustekinumab) from Johnson & Johnson (NYSE: JNJ) in adult patients with moderate to severe ulcerative colitis who …
Read More »